Caris Life Sciences, Inc.

CAINASDAQHealthcare● Active

$16.12

$-0.37(-2.24%)

Market Cap$4.6B

P/E Ratio—

52W High$42.5

52W Low$14.19

Avg Volume2.6M

Open$17.43

Beta0.79

Net Income Financials Revenue

Caris Life Sciences, Inc. (CAI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CAI · net income · updated Jun 8, 2026

Core profitability metrics

CAI · net income · margin · TTM · CAGR

Net income was −$538.0M for FY2025 (fiscal year ending 2025-12-31), down 90.8% year-over-year. Net profit margin was -66.3%. Based on available data, Caris Life Sciences, Inc. has been profitable since at least 2010.

FY2025 Net Income−$538.0M▼ -90.8% YoY

Trailing 12M (TTM)$34.0Mtrailing 4 quarters sum

Net Profit Margin-66.3%−$538.0M ÷ $812.0M

YoY Change-90.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2010

▸ FMP /income-statement · Annual · CAI net income history · CAI profit margin

Annual net income data

CAI · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$538.0M▼ 90.8%-66.3%$812.0M

FY2024Loss−$281.9M▲ +17.4%-68.4%$412.3M

FY2023Loss−$341.4M▼ 6.4%-111.5%$306.1M

FY2022Loss−$320.8M▼ 1256.8%-124.1%$258.5M

FY2020$27.7M▼ 10.6%9.4%$294.0M

Net income vs peers (Healthcare)

CAI vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Caris Life Sciences, Inc.YOU

CAI

−$538.0M-90.8%-66.3%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Caris Life Sciences, Inc. (CAI) reported net income of −$538.0M for FY2025 (fiscal year ending 2025-12-31), down 90.8% year-over-year. The net profit margin was -66.3% — meaning the company kept $-0.66 of every dollar of revenue as profit.

Based on available data, Caris Life Sciences, Inc. has been profitable since at least 2010. Net income reached a peak of $78.6M in FY2018. Data available for 15 fiscal years.

Caris Life Sciences, Inc.'s net profit margin was -66.3% for FY2025, based on the latest annual results.

Investors sometimes search for "Caris Life Sciences, Inc. net worth" — the company's market capitalization is a separate figure from CAI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CAI net income · 5 questions

Caris Life Sciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $538.0M for FY2025.

is CAI profitabledoes CAI make a profitCAI profitabilityCAI profitable company

▸ Source: FMP /income-statement · GAAP · Caris Life Sciences, Inc. · Caris Life Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026